NCT03195491
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03195491
Title A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia (CheckMate870)
Acronym CheckMate870
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Local Institution Beijing Beijing Municipality 100001 China Details
Local Institution Beijing Beijing Municipality 100142 China Details
Local Institution Beijing Beijing Municipality 100730 China Details
Local Institution Beijing Beijing Municipality 101149 China Details
Local Institution Fuzhou Fujian 350014 China Details
Local Institution Guangzhou Guangdong 510080 China Details
Local Institution Beijingcun Hebei 100031 China Details
Local Institution Harbin Heilongjiang 150081 China Details
Local Institution Zhengzhou Henan 450008 China Details
Local Institution Wuhan Hubei 430022 China Details
Local Institution - 0017 Changsha Hunan 410013 China Details
Local Institution Nanjing Jiangsu 210002 China Details
Local Institution Nanjing Jiangsu 210008 China Details
Local Institution Changchun Jilin 130012 China Details
Local Institution Changchun Jilin 130021 China Details
Local Institution Xi'an Shan3xi 710038 China Details
Local Institution Jinan Shandong 250031 China Details
Local Institution Shanghai Shanghai Municipality 200025 China Details
Local Institution Shanghai Shanghai Municipality 200032 China Details
Local Institution Tianjin Tianjin Municipality 300222 China Details
Local Institution Ürümqi Xinjiang 830011 China Details
Local Institution Hangzhou Zhejiang 310000 China Details
Local Institution Hangzhou Zhejiang 310003 China Details
Local Institution Hangzhou Zhejiang 310022 China Details
Local Institution Guangzhou China Details
Local Institution Shanghai 200030 China Details
Local Institution Shanghai 200032 China Details
Local Institution Shenyang 110042 China Details
Local Institution Bangkok 10700 Thailand Details
Local Institution Khon Kaen 40002 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field